{"organizations": [], "uuid": "3008a2928977e693dd4eb79cd530418058211156", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-cytrx-presents-statistically-signi/brief-cytrx-presents-statistically-significant-breakthrough-data-for-its-albumin-binding-ultra-high-potency-ladr-drug-candidates-idUSFWN1RV0K1", "country": "US", "domain_rank": 408, "title": "BRIEF-Cytrx Presents Statistically Significant Breakthrough Data For Its Albumin Binding Ultra High Potency Ladr Drug Candidates", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-18T15:14:00.000+03:00", "replies_count": 0, "uuid": "3008a2928977e693dd4eb79cd530418058211156"}, "author": "", "url": "https://www.reuters.com/article/brief-cytrx-presents-statistically-signi/brief-cytrx-presents-statistically-significant-breakthrough-data-for-its-albumin-binding-ultra-high-potency-ladr-drug-candidates-idUSFWN1RV0K1", "ord_in_thread": 0, "title": "BRIEF-Cytrx Presents Statistically Significant Breakthrough Data For Its Albumin Binding Ultra High Potency Ladr Drug Candidates", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "cytrx corp", "sentiment": "none"}, {"name": "cytrx corp", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "cytrx", "sentiment": "none"}, {"name": "ultra high potency ladr drug candidates reuters staff", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 18, 2018 / 12:15 PM / Updated 10 minutes ago BRIEF-Cytrx Presents Statistically Significant Breakthrough Data For Its Albumin Binding Ultra High Potency Ladr Drug Candidates Reuters Staff 1 Min Read \nCytRx Corp: \n* CYTRX PRESENTS STATISTICALLY SIGNIFICANT BREAKTHROUGH DATA FOR ITS ALBUMIN BINDING ULTRA HIGH POTENCY LADR DRUG CANDIDATES \n* CYTRX CORP - GOAL OF FILING IND APPLICATIONS ON ONE OR MORE DRUG CANDIDATES IN 2018 Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-18T15:14:00.000+03:00", "crawled": "2018-04-18T15:29:45.045+03:00", "highlightTitle": ""}